SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (3853)5/30/2001 11:43:05 PM
From: Mad2  Read Replies (1) of 5582
 
I agree that GUMM might have some potential, assuming the deal with wrigley goes through and pending with the other stuff (nicotine JV & ZICAM).
valuation is becomming reasonable, still speculative but if one takes a optimistic view a least some upside (based on that view).
given GUMM's gum operation was a looser, I doubt that wrigley bought the operation for their "manufacturing", maybe formuls and niche potential.
mad2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News